Gene · 11331
Papers2,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clopidogrel-induced Eosinophilia with Hypercalcemia. | Intern Med | 2022 | 35135910 | PubTator, text mining | PubMed |
| Mitophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention. | Oxid Med Cell Longev | 2022 | 35126814 | PubTator, text mining | PubMed |
| The Yun/Prohibitin complex regulates adult Drosophila intestinal stem cell proliferation through the transcription factor E2F1. | Proc Natl Acad Sci U S A | 2022 | 35115400 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Hepatitis B virus. | Virulence | 2022 | 35100095 | PubTator, text mining | PubMed |
| In Vitro Regeneration of Korarima (Aframomum corrorima (Braun) P. C. M. Jansen): A Threatened Spice and Medicinal Herb from Ethiopia. | Scientifica (Cairo) | 2022 | 35096435 | PubTator, text mining | PubMed |
| Structural biology of SARS-CoV-2: open the door for novel therapies. | Signal Transduct Target Ther | 2022 | 35087058 | PubTator, text mining | PubMed |
| Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning. | ERJ Open Res | 2022 | 35083319 | PubTator, text mining | PubMed |
| Effects of vitamin D-fortified oil intake versus vitamin D supplementation on vitamin D status and bone turnover factors: A double blind randomized clinical trial. | Clin Nutr ESPEN | 2022 | 35063214 | PubTator, text mining | PubMed |
| Seaweed-Derived Proteins and Peptides: Promising Marine Bioactives. | Antioxidants (Basel) | 2022 | 35052680 | PubTator, text mining | PubMed |
| Development of a Chemiluminescence Assay for Total N-Terminal Propeptide of Type I Collagen and Its Evaluation in Lung Transplantation. | J Anal Methods Chem | 2022 | 35047228 | PubTator, text mining | PubMed |
| Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives. | Biol Rev Camb Philos Soc | 2022 | 35043558 | PubTator, text mining | PubMed |
| Effect of n-3 polyunsaturated fatty acid on bone health: A systematic review and meta-analysis of randomized controlled trials. | Food Sci Nutr | 2022 | 35035917 | PubTator, text mining | PubMed |
| Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. | J Biol Chem | 2022 | 35032548 | PubTator, text mining | PubMed |
| Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case report. | Bone Rep | 2022 | 35024386 | PubTator, text mining | PubMed |
| Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | Mol Cell Proteomics | 2022 | 35007762 | PubTator, text mining | PubMed |
| Recent advances in, and challenges of, designing OMA1 drug screens. | Pharmacol Res | 2022 | 34999225 | PubTator, text mining | PubMed |
| Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women. | Sci Rep | 2022 | 34997107 | PubTator, text mining | PubMed |
| MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling. | Mol Cancer Res | 2022 | 34992146 | PubTator, text mining | PubMed |
| Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study. | Neuroradiology | 2022 | 34984522 | PubTator, text mining | PubMed |
| The SWI/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo. | PLoS Genet | 2022 | 34982771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11331/papers?page=41